Brief: Amphastar Pharmaceuticals Receives FDA Approval For Atropine Sulfate Injection

Amphastar Pharmaceuticals,

06/10/2020 11:03

Oct 6 (Reuters) - Amphastar Pharmaceuticals Inc  AMPH.O :
    * AMPHASTAR PHARMACEUTICALS RECEIVES FDA APPROVAL FOR
ATROPINE
SULFATE INJECTION
    * AMPHASTAR PHARMACEUTICALS INC - NET REVENUES FOR COMPANY'S
ATROPINE SULFATE INJECTION FOR YEAR ENDED DECEMBER 31, 2019 WERE
$12.2 MILLION
    * AMPHASTAR PHARMACEUTICALS - FDA APPROVED ANDA FOR ATROPINE
SULFATE INJECTION 0.1MG/ML IN 10 ML LUER-JET PREFILLED SYRINGE
SYSTEM

Source text for Eikon:  ID:nGNX4WBp1c 
Further company coverage:  AMPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))